Sell, Sell, Sell

Too many in the scientific community, particularly those who control the funding, regard the commercialization of science as something "dirty," says the University of Leeds' Deputy Vice-Chancellor John Fisher in New Scientist. They say "that inspiration alone should be the driving force behind scientific labor," but this is just a "myth," Fisher says.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

In a survey, about half of Canadian government scientists say they still feel as though they cannot speak freely, ScienceInsider reports.

The Atlantic reports that biohacker Josiah Zayner regrets injecting himself with the CRISPR gene-editing tool on stage.

Clinicians in China are moving ahead with a number of CRISPR trials, NPR reports, as the US embarks on its first.

In Nature this week: genomic approaches applied to study Neolithic and Bronze Age Europeans, and more.